COMP <GO>
BKD vs JNJ // DIVIDEND YIELD & FCF PAYOUT SAFETY
Brookdale Senior Living Inc. (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: BKD 0
— JNJ 11
■ METRIC PARITY
LAST: $10.27 (+2.91%) • MKT CAP: $2.45B
dividend-safety
0.00%
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BKD VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BKD | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 26.20% | 67.90% | -41.70 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.30% | 25.50% | -25.20 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 34.6x | 18.5x | +16.10 | JNJ | /valuation <GO> |
| Free Cash Flow Yield | 0.67% | 2.97% | -2.30 | JNJ | /fcf-yield <GO> |
| Operating Margin | 0.40% | 34.70% | -34.30 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -8.20% | 28.50% | -36.70 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 2.20% | 6.00% | -3.80 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.59 | -5.39 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.0 | 62.1 | -16.10 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.45B | $662.49B | -$660.04B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BKD REV | JNJ REV | BKD GROSS % | JNJ GROSS % | BKD FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.19B | $94.19B | 26.2% | 67.9% | $16.5M | $19.70B |
| FY 2024 | $3.13B | $88.82B | 25.6% | 69.1% | -$35.1M | $19.84B |
| FY 2023 | $3.02B | $85.16B | — | — | $162.9M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BKD // BETA —
JNJ // BETA 1.08